Abstract
There is a paucity of studies investigating the impact of mid-range ejection fraction (mrEF) on clinical outcomes, including ventricular arrhythmias, in ST-segment-elevation myocardial infarction (STEMI). We sought to investigate the prognostic role of mrEF post STEMI and whether recommended medical therapy may modify future risk. 533 consecutive patients from a single large-volume centre who underwent primary percutaneous coronary intervention were included. Reduced EF (<40%), mrEF (40-49%) and preserved EF (≥50%) were defined according to the European Society of Cardiology guidelines. Clinical outcomes were prospectively collected, and the primary endpoint was defined as the composite of death, re-admission with heart failure, sustained ventricular arrhythmia requiring hospitalisation or implantable cardioverter defibrillator over three years follow-up. There was a stepwise increase in the primary endpoint according to EF group (8%, 17%, 30%, P < .001), which was derived from each individual component. Compared to preserved EF, patients with mrEF had significantly higher risk [HR 4.08 (95%CI 2.38 to 6.99), P < .001]. The use of suboptimal medical therapy was associated with increased future risk, particularly in mrEF [HR 2.62...Continue Reading
References
Apr 1, 1984·Statistics in Medicine·F E HarrellR A Rosati
Dec 21, 1995·The New England Journal of Medicine·L KøberN C Pauly
May 18, 2001·Lancet·H J Dargie
Sep 21, 2002·Lancet·Kenneth DicksteinUNKNOWN OPTIMAAL Steering Committee of the OPTIMAAL Study Group
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
Sep 24, 2004·The New England Journal of Medicine·Nagesh S AnavekarMarc A Pfeffer
May 3, 2005·Journal of the American College of Cardiology·Amir HalkinGregg W Stone
Dec 7, 2005·Circulation·Scott D SolomonUNKNOWN Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators
Dec 13, 2006·Journal of the American College of Cardiology·Takanori IkedaTakao Kato
Jun 3, 2011·Circulation·Jeffrey J GoldbergerDouglas P Zipes
Apr 11, 2014·The New England Journal of Medicine·Bertram PittUNKNOWN TOPCAT Investigators
Sep 12, 2014·European Journal of Heart Failure·Carolyn S P Lam, Scott D Solomon
May 22, 2016·European Heart Journal·Piotr PonikowskiUNKNOWN ESC Scientific Document Group
May 22, 2016·European Journal of Heart Failure·Piotr PonikowskiUNKNOWN Document Reviewers
Jun 4, 2016·JACC. Heart Failure·John R KapoorGregg C Fonarow
Jun 4, 2016·JACC. Heart Failure·Carolyn S P Lam, Tiew-Hwa Katherine Teng
Apr 5, 2017·Circulation·Carolyn S P Lam, Scott D Solomon
May 24, 2017·The American Journal of Cardiology·Gilad MargolisYacov Shacham
Jun 3, 2017·Journal of the American College of Cardiology·Tatendashe B DondoChris P Gale
Sep 10, 2017·European Heart Journal·Borja IbanezUNKNOWN ESC Scientific Document Group
Aug 24, 2018·Acta Cardiologica·Yavuz KarabağVeysel Ozan Tanık
Nov 18, 2018·Therapeutic Advances in Cardiovascular Disease·Talal AlzahraniAllen Solomon
Feb 5, 2019·European Heart Journal. Acute Cardiovascular Care·Fernando Montenegro SáUNKNOWN Portuguese Registry of Acute Coronary Syndrome Investigators
May 3, 2019·European Heart Journal·Konstantinos A GatzoulisDimitrios Tousoulis
Sep 5, 2019·Clinical Cardiology·João Pedro FerreiraFaiez Zannad
Dec 2, 2019·The Canadian Journal of Cardiology·Mohammad AlkhalilMark S Spence